• Users Online: 337
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Ahead of print Current issue Search Archives Submit article Instructions Subscribe Contacts Login 
Year : 2019  |  Volume : 3  |  Issue : 3  |  Page : 42-52

A practical, evidence-based approach to postneonatal management of children with bronchopulmonary dysplasia

1 Queens Medical Centre, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Nottingham, England
2 Department of Paediatrics, Kwong Wah Hospital, Yau Ma Tei, Hong Kong

Correspondence Address:
Jayesh Mahendra Bhatt
Queens Medical Centre, Nottingham Children's Hospital, Nottingham University Hospitals NHS Trust, Derby Road, Nottingham NG7 2UH
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/prcm.prcm_2_20

Rights and Permissions

Despite increasing survival for babies born preterm, the incidence of bronchopulmonary dysplasia (BPD) remains similar and continues to be the most common chronic lung disease in the preterm population. Advances in neonatal management, including the use of antenatal steroids, exogenous surfactants and changes in ventilation, have resulted in a change in the pathophysiology of BPD to a condition characterized by an arrest in alveolar development and vascular remodeling. There are numerous diagnostic definitions used for this heterogeneous condition with those using the extent of respiratory support required at 36 weeks postmenstrual age shown to be the most effective in predicting long-term pulmonary outcomes. In this article, we will discuss definitions, etiology, and pathophysiology of BPD. Management of infants with established BPD requires a multi-disciplinary team, including neonatologists and respiratory pediatricians with support for families being crucial to long term care. In this article, we will review current guidelines on oxygen saturation targets for established BPD and discuss how the use of a structured weaning pathway, as used at our center, has been shown to reduce the total duration of home oxygen. Other cornerstones of management, including optimizing growth and nutrition, reducing second-hand smoke exposure, and infection prevention, are discussed. For infants with the most severe BPD, we will review the evidence base for pharmacological therapies and indications for long-term ventilatory support. With a number of emerging therapies such as mesenchymal stem cells at the stage of phase one clinical trials, we will discuss future directions in BPD management.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded367    
    Comments [Add]    

Recommend this journal